Trimi GLP-1 Review (2026): Pricing, Coverage, and Tradeoffs

Item: Trimi
Author: RangeYourself

Trimi review, semaglutide compounded, $99/mo on the annual plan, billed yearly ($1,188/yr up front). verified 2026-08-21 (unchanged since 2026-07-14)., tirzepatide compounded, $125/mo on the annual plan (billed yearly). verified 2026-08-21 (unchanged since 2026-07-14).. Lowest-cost compounded GLP-1 on an annual plan with a plain 503A disclosure. Independent 2026 review from RangeYourself.

By RangeYourselfLast verified 2026-08-21

Quick take

Trimi is compounded semaglutide and compounded tirzepatide, once-weekly at-home injection, priced as flat-membership subscription billed yearly (annual commitment tier); one price covers medication, clinician visits, check-ins, shipping; no separate membership fee; no insurance. Best for: Lowest-cost compounded GLP-1 on an annual plan with a plain 503A disclosure. Watch out for: The $99/mo semaglutide and $125/mo tirzepatide rates are the ANNUAL plan, BILLED YEARLY (semaglutide = $1,188 charged up front). A month-to-month rate is not published, confirm billing terms before enrolling.

Pricing summary

Price verified: 2026-08-21 (checked against the provider’s public pricing surface)
All-in monthly cost: $99/month (medication included), annual-plan rate
Semaglutide: Compounded, $99/mo on the annual plan, BILLED YEARLY ($1,188/yr up front). Verified 2026-08-21 (unchanged since 2026-07-14).
Tirzepatide: Compounded, $125/mo on the annual plan (billed yearly). Verified 2026-08-21 (unchanged since 2026-07-14).
Compounded vs brand-name: Compounded only
Insurance accepted: No insurance-billing path published (cash-pay); confirm at signup
Consult type: Async questionnaire, per the provider’s published flow
Dose-escalation pricing: $99/mo (semaglutide) and $125/mo (tirzepatide) are the annual-plan flat rates billed yearly; per-dose escalation and any month-to-month rate are not published, confirm at intake.
Refund policy: Conditional 6-month weight-loss guarantee: 'Follow your plan for 6 months and if you don’t lose weight, you can request a refund. Terms apply.'
States served: All 50 US states + Washington, D.C.

See Trimi pricing →

Choose Trimi if

You want the lowest-cost compounded semaglutide ($99/mo) or tirzepatide ($125/mo) with everything bundled
You’re comfortable with an annual plan billed yearly ($1,188 up front for semaglutide)
You value an upfront '503A compounding pharmacy' and 'not FDA-approved' disclosure
You want care via a 50-state clinical network (Arora Health) with free shipping

Skip Trimi if

You want a month-to-month (non-annual) plan, insurance billing, or a brand-name (non-compounded) GLP-1.

Contraindications and clinical notes

Standard GLP-1 contraindications per GLP-1 prescribing information (personal/family history of MTC or MEN 2). Every prescription reviewed by a licensed U.S. provider before it ships.. Talk to a clinician about personal or family history of medullary thyroid carcinoma, MEN 2, pancreatitis, or other conditions before starting any GLP-1 medication.

Verified programs that cost less than Trimi

Trimi’s own verified figure is $99/mo (annual-plan rate). Every program below carries a lower all-in monthly price that we verified on the provider’s own pricing page, ranked lowest first as of September 3, 2026.

1.Embody
$69/mo (limited-time promo), verified August 21, 2026
See pricing →

Prices are each provider’s own published all-in monthly figure at the plan term shown, verified on the date listed. RangeYourself may earn a commission from some programs; that can only break an exact tie between verified equals and never changes the price order.

How Trimi compares

Frequently asked questions

How much does Trimi cost per month?

Trimi's lowest verified rate is $99/month with compounded medication included, and that figure is its annual-plan rate rather than a month-to-month price. Semaglutide: Compounded, $99/mo on the annual plan, BILLED YEARLY ($1,188/yr up front). Verified 2026-08-21 (unchanged since 2026-07-14).; tirzepatide: Compounded, $125/mo on the annual plan (billed yearly). Verified 2026-08-21 (unchanged since 2026-07-14).. $99/mo (semaglutide) and $125/mo (tirzepatide) are the annual-plan flat rates billed yearly; per-dose escalation and any month-to-month rate are not published, confirm at intake.

Does Trimi accept insurance?

Trimi publishes cash-pay prices and we found no insurance-billing path on its own site. Where a provider's own FAQ leaves the door open, the answer sits inside its intake flow, which we do not enter, so confirm at signup rather than treating this as settled. If you want insurance-billed brand-name GLP-1, see our list of GLP-1 programs that accept insurance.

What states does Trimi serve?

Trimi ships medication to all 50 US states plus Washington, D.C.

Is Trimi compounded or brand-name?

Trimi prescribes compounded semaglutide and tirzepatide via state-licensed 503A pharmacies or 503B outsourcing facilities. Compounded medication is not individually FDA-approved. The shortage-era compounding pathway ended after the FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so compounding now proceeds under the ordinary rules for individual patients.

What's the catch with Trimi?

The $99/mo semaglutide and $125/mo tirzepatide rates are the ANNUAL plan, BILLED YEARLY (semaglutide = $1,188 charged up front). A month-to-month rate is not published, confirm billing terms before enrolling. Avoid if: you want a month-to-month (non-annual) plan, insurance billing, or a brand-name (non-compounded) glp-1.

What the records show

Trimi is the one provider in our dataset with a Trustpilot rating actively suppressed for a guideline-breach warning, Trustpilot's own explanation, not our characterization, and we found no BBB listing to cross-reference. Individual reviews are still visible on the profile even though the aggregate score isn't.

Trustpilot: rating unavailable, Trustpilot displays a guideline-breach warning on this profile: “This company’s rating is unavailable due to a breach of our guidelines.” No numeric rating or review count is shown, individual reviews are still visible on the page, but Trustpilot has suppressed the aggregate score. (via Trustpilot, checked 2026-07-24)

Independently observed third-party data, not our own editorial score. Full methodology: GLP-1 Provider Reliability Report.

Related guides

Trimi availability by state

GLP-1 programs in California , where Trimi ships and how it stacks up locally.
GLP-1 programs in Texas , where Trimi ships and how it stacks up locally.
GLP-1 programs in Florida , where Trimi ships and how it stacks up locally.
GLP-1 programs in New York , where Trimi ships and how it stacks up locally.
GLP-1 programs in Illinois , where Trimi ships and how it stacks up locally.

About compounded GLP-1 medicationsCompounded semaglutide and tirzepatide are not FDA-approved finished products. They are prepared by state-licensed 503A pharmacies or 503B outsourcing facilities and are not individually reviewed by the FDA for safety, effectiveness, or quality. Compounders describe these preparations as using the same active ingredient as the approved medicines; the FDA has warned that some compounded products use salt forms, semaglutide sodium or semaglutide acetate, that it considers different active ingredients from the approved drug, and has issued warning letters over marketing that presents a compounded preparation as interchangeable with an approved one. The FDA declared the semaglutide shortage resolved on February 21, 2025 and the tirzepatide shortage resolved in December 2024, so the shortage-era pathway for broad compounding of these drugs has ended. Compounding now proceeds under the ordinary rules: a 503A pharmacy compounding for an individual patient on a prescription, or a 503B outsourcing facility, which compounds in bulk under CGMP and FDA registration rather than per patient. Those rules generally do not cover a product that is “essentially a copy” of an approved drug unless a prescriber documents a change that makes a significant difference for an individual patient. Talk to a clinician about contraindications including personal or family history of medullary thyroid carcinoma or MEN 2. RangeYourself does not provide medical advice, does not guarantee a prescription, and does not guarantee weight-loss results.

RangeYourself is reader-supported. We may earn a commission when you click on certain links, at no extra cost to you. Editorial recommendations are made independently. Pricing reflects publicly listed entry tiers verified on 2026-08-21 and may change.